Loading...
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
Patients with CKD often progress to ESRD and develop cardiovascular disease (CVD), yet available therapies only modestly improve clinical outcomes. Observational studies report independent associations between elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels and risks of ESRD,...
Na minha lista:
| Udgivet i: | J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Nephrology
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4587706/ https://ncbi.nlm.nih.gov/pubmed/25967123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015020117 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|